Guidelines emphasize single-pill combinations and deprescribing strategies to combat polypharmacy and hyperpolypharmacy in ...
In patients starting gout medication, hitting a target serum urate level below 6 mg/dL reduces the risk of major ...
FDA requests Tavneos market withdrawal due to ADVOCATE trial assessment concerns; Amgen maintains the drug's benefit-risk profile remains positive.
Heart failure management includes the four pillars (quad therapy) in HFrEF and HFpEF, plus advances in heart transplantation and gene editing.
Men have a significantly higher risk for premature cardiovascular disease (CVD) and a significantly earlier onset compared with women.
Most US adults have heard of statins to lower cholesterol, but many do not know there are nonstatin medications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results